Financials

News Discussions Technicals Seasonals

PCRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMACORP RX INC operating, investing, and financing activities

PCRX free cash flow for Q2 24 is -164.28 k CAD. For 2023, PCRX free cash flow was -519.46 k CAD and operating cash flow was -519.46 k CAD.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CAD

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—